Authors:
Kiran Pulidindi, Kunal Ahuja
Download free PDF
Marine Protein Hydrolysate Market Size & Share 2026-2035
Report ID: GMI7553
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Marine Protein Hydrolysate Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Marine Protein Hydrolysate Market Size
The marine protein hydrolysate market was valued at USD 291.6 million in 2025, is projected to reach USD 301.2 million in 2026, and is expected to grow at a 4.5% CAGR (2026–2035) to reach USD 452.1 million by 2035.
Marine Protein Hydrolysate Market Key Takeaways
Market Leader: Hofseth BioCare ASA led with over 7.9% market share in 2025.
Leading Players: Top 5 players in this market include Hofseth BioCare ASA, Copalis Sea Solutions, Omega Protein Corporation, Darling Ingredients Inc., Seagarden AS, which collectively held a market share of 29.1% in 2025.
The marine protein hydrolysate market is moving beyond its historical dependence on bulk feed use as processors monetize seafood by-products through ingredients with more defined functional roles. Aquaculture remains the volume anchor, while demand from pet nutrition, clinical formulations, cosmetics, and agricultural inputs broadens the value mix and raises the importance of traceable feedstock, peptide characterization, and application-specific processing.
GMI Analyst View
Based on GMI's review of production benchmarks and supply-chain participant discussions, the marine protein hydrolysate market entered the current forecast period from an estimated base of USD 245.0 million in 2022. We view this progression as evidence of structural demand formation: aquaculture expansion, premiumization in pet and human nutrition, and the integration of marine by-products into higher-value ingredient supply chains are creating a more durable basis for growth than a cyclical feed-market recovery alone.
Marine Protein Hydrolysate Market Trends, Growth Drivers & GMI Forecast Outlook
Demand is being shaped by the interaction of feed-performance requirements, seafood by-product availability, and the growing commercial relevance of bioactive marine peptides. The forecast favors suppliers that can pair reliable raw-material access with differentiated processing and documentation suited to premium nutrition channels.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Aquaculture's increasing centrality to aquatic-food production has changed the procurement logic for feed inputs. Farms operating intensive salmon, shrimp, and marine finfish systems require ingredients that support palatability, early-life nutrition, and feed efficiency under demanding biological conditions. This gives hydrolysates a functional role that is more defensible than undifferentiated protein inclusion, particularly in juvenile and stress-sensitive production stages.
By-product utilization is equally consequential because it links supply resilience with sustainability positioning. Processors that recover proteins from trimmings, frames, skins, and viscera can improve raw-material economics while helping downstream customers address circularity requirements. The commercial advantage is strongest where manufacturers can maintain consistent specifications despite variability in species mix and processing yields.
The premium opportunity rests on controlled peptide fractionation rather than on marine origin alone. Enzymatic processing can create targeted fractions for formulations that value solubility, bioavailability, and substantiated functional attributes. That shift raises the strategic importance of analytical capability, quality systems, and clinical or formulation evidence for suppliers seeking to serve nutrition, personal care, and specialized health applications.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Climate exposure remains a material concern for producers dependent on pelagic raw materials. Disruption in a concentrated wild-capture supply chain can quickly alter input availability, inventory decisions, and margins for hydrolysates positioned in price-sensitive feed formulations. Broader use of aquaculture-derived trimmings and diversified by-product streams can reduce, but not fully remove, this exposure.
Alternative proteins are exerting a different form of pressure. Feed formulators can reduce conventional marine protein inclusion when cost becomes the dominant criterion, especially in shrimp diets. Hydrolysate suppliers therefore need to demonstrate specific performance benefits, such as improved palatability or feed-conversion outcomes, rather than relying on marine provenance as their primary commercial proposition.
Allergen-control obligations introduce additional complexity as suppliers move into food-grade and clinical applications. Species-level traceability, segregated handling, labeling discipline, and documentation can lengthen development cycles and constrain blended-source formulation strategies. These requirements create a higher barrier to entry, but they also favor producers with established quality and regulatory capabilities.
GMI Analyst View
We expect value creation to shift gradually toward suppliers that can establish a functional, evidence-led proposition rather than compete only on protein availability. Commodity aquafeed demand will remain important, yet its economics are more exposed to input volatility and substitution. The more differentiated opportunity lies in applications where peptide profile, traceability, and regulatory readiness support pricing power.
Marine Protein Hydrolysate Market Segment Analysis
By Source
Finfish. The marine protein hydrolysate market's finfish segment is projected to reach USD 230.0 million by 2035 and expand at a 4.2% CAGR (2026–2035). Its scale reflects established processing infrastructure for salmon, tuna, cod, and small pelagic species, which provides a comparatively mature base of recoverable protein streams for feed and higher-value ingredient production.
Salmon. Salmon hydrolysates generated USD 67.1 million in 2025 and are projected to reach USD 102.6 million by 2035. High-value utilization is supported by the availability of salmon-processing co-products and the suitability of salmon-derived fractions for premium pet nutrition, sports nutrition, and cosmetic formulations where product provenance and composition are commercially relevant.
Sardine & Anchovy. Sardine & anchovy hydrolysates generated USD 26.2 million in 2025 and are expected to grow at a 4.5% CAGR (2026–2035). Their commercial role is closely tied to pelagic-processing supply chains and use in aquafeed systems where soluble peptides can support palatability and feed acceptance, although exposure to catch variability remains a procurement consideration.
Tilapia. Tilapia hydrolysates are projected to reach USD 14.9 million by 2035 and grow at a 5.5% CAGR (2026–2035). Freshwater aquaculture processing is expanding the availability of tilapia by-products, particularly across Asian production corridors, creating an increasingly relevant feedstock for manufacturers seeking regional supply proximity.
Crustaceans. Crustacean-derived hydrolysates are projected to reach USD 131.1 million by 2035, while accounting for 28.0% of market revenue in 2025. Shellfish-processing streams provide differentiated material for feed and specialty uses, though raw-material handling and allergen-control demands increase the operational requirements for suppliers targeting food-grade channels.
Shrimp & Prawn. Shrimp & prawn hydrolysates generated USD 49.6 million in 2025 and are forecast to grow at a 4.8% CAGR (2026–2035). Their relevance in juvenile aquatic diets stems from palatability and digestibility characteristics, while the scale of shrimp-processing by-products supports a geographically diverse supply base across Southeast Asia and Latin America.
Krill. Krill hydrolysates are projected to reach USD 39.8 million by 2035 and expand at a 5.5% CAGR (2026–2035). Their positioning is more premium than volume-led, with phospholipid-associated peptide matrices and sustainability narratives supporting use in nutritional supplements and specialized human-health formulations.
Mollusks. Mollusk-derived hydrolysates represented 13.0% of market revenue in 2025 and are projected to grow at a 4.4% CAGR (2026–2035). Oyster, mussel, squid, and scallop sources occupy specialized positions in food, nutraceutical, and functional-ingredient applications, particularly in markets with established demand for marine-derived bioactives.
By Form
Spray-Dried. Spray-dried hydrolysates generated USD 93.3 million in 2025 and represented 32.0% of market revenue. Ambient stability, consistent handling characteristics, and broad formulation compatibility make this format particularly relevant to pet food, dietary supplements, and other applications that require standardized dry inputs.
Freeze-Dried. Freeze-dried hydrolysates are projected to reach USD 53.1 million by 2035 and grow at a 6.2% CAGR (2026–2035). The format's appeal lies in preserving more sensitive bioactive fractions, which supports its use in premium clinical, pharmaceutical, and cosmetic applications where functional integrity can justify higher processing costs.
Liquid. Liquid hydrolysates are projected to reach USD 188.9 million by 2035 and expand at a 4.2% CAGR (2026–2035). Their continued importance is rooted in direct integration into aquaculture and animal-feed operations, where soluble peptide availability and straightforward incorporation can outweigh transport and storage limitations.
Paste. Paste hydrolysates generated USD 43.7 million in 2025 and are expected to grow at a 3.7% CAGR (2026–2035). The format retains relevance in larval feeds and selected bait applications, but narrower handling flexibility limits its ability to match the logistical advantages of liquid or dry alternatives across broader commercial channels.
By Application
Aquaculture Feed. Aquaculture feed generated USD 67.1 million in 2025 and is expected to grow at a 3.5% CAGR (2026–2035). The segment remains the principal volume outlet because hydrolysates can support feed acceptance and nutritional performance in early-life and high-intensity farming systems, even as formulators balance marine inputs against lower-cost alternatives.
Animal & Livestock Feed. Animal & livestock feed generated USD 35.0 million in 2025 and is projected to reach USD 47.2 million by 2035. Demand is concentrated in diets where digestibility matters, including young-animal nutrition, but adoption remains sensitive to competition from plant-derived protein ingredients and broader feed-cost conditions.
Pet Food. Pet food is projected to reach USD 63.5 million by 2035 and grow at a 4.5% CAGR (2026–2035). Marine hydrolysates serve as palatability enhancers and digestible protein ingredients in premium formulations, where pet-owner interest in recognizable, function-oriented nutrition helps sustain demand.
Food & Beverages. Food & beverages generated USD 29.2 million in 2025 and are projected to reach USD 43.3 million by 2035. Use cases center on protein fortification, functional beverages, and savory flavor systems, where short-chain peptides and free amino acids can contribute both nutritional and sensory value.
Sports Nutrition & Dietary Supplements. Sports nutrition & dietary supplements are projected to reach USD 47.7 million by 2035 and expand at a 5.0% CAGR (2026–2035). Growth depends on consumer interest in non-bovine protein formats and on suppliers' ability to translate marine-peptide characteristics into credible recovery, bioavailability, and wellness positioning.
Clinical Nutrition & Medical Foods. Clinical nutrition & medical foods are projected to reach USD 43.8 million by 2035 and grow at a 6.5% CAGR (2026–2035). This application favors high-quality, readily absorbed protein ingredients for specialized formulations, making documentation, consistency, and regulatory readiness more commercially decisive than scale alone.
Cosmetics & Personal Care. Cosmetics & personal care generated USD 23.3 million in 2025 and are projected to reach USD 38.0 million by 2035. Demand is supported by interest in marine-origin peptides for skin-care and hair-care products, where low-molecular-weight fractions and premium sourcing narratives complement formulation performance claims.
Pharmaceuticals & Therapeutics. Pharmaceuticals & therapeutics generated USD 17.5 million in 2025 and are expected to grow at a 6.0% CAGR (2026–2035). This technically demanding segment requires robust processing controls and evidence standards, but it offers suppliers an avenue to monetize specialized peptide fractions beyond commodity ingredient markets.
Agriculture (Biostimulants). Agriculture biostimulants are projected to reach USD 28.6 million by 2035 and grow at a 7.0% CAGR (2026–2035). Marine hydrolysates can support crop-nutrition and stress-tolerance programs, creating a distinct growth avenue for processors that can meet product-registration, agronomic-validation, and channel-development requirements.
GMI Analyst View
We see the segment mix becoming more commercially sophisticated rather than simply more diverse. Feed applications will continue to provide scale, but the strongest strategic positions will accrue to suppliers that align a distinct source material and processing format with a use case where functionality can be demonstrated and monetized. That logic favors application-specific portfolios over broad, undifferentiated output.
Marine Protein Hydrolysate Market Regional Analysis
North America Marine Protein Hydrolysate Market Analysis
The marine protein hydrolysate market in North America generated USD 87.5 million in 2025 and is expected to grow at a 4.2% CAGR (2026–2035). Regional demand combines established marine-ingredient processing with mature pet-food, sports-nutrition, and functional-food channels, creating an environment that rewards product consistency, regulatory compliance, and documented ingredient performance.
United States. The United States generated USD 70.0 million in 2025 and is projected to reach USD 105.9 million by 2035. Gulf Coast menhaden processing supports feed-oriented supply, while premium pet food and human nutrition channels create demand for more differentiated marine-derived ingredients.
Canada. Canada is projected to reach USD 26.5 million by 2035 and expand at a 4.2% CAGR (2026–2035). Salmon aquaculture and Atlantic seafood-processing infrastructure provide both feedstock and application demand, with circular-economy initiatives supporting greater recovery of processing co-products.
Europe Marine Protein Hydrolysate Market Analysis
Europe is projected to reach USD 117.8 million by 2035 and accounted for 27.0% of market revenue in 2025. The region's advanced seafood-processing base and demand for traceable, premium ingredients support a diversified opportunity across aquafeed, nutrition, cosmetics, and biostimulants, while regulatory requirements elevate the importance of technical documentation.
Germany. Germany generated USD 14.2 million in 2025 and is projected to reach USD 21.2 million by 2035. Its large food, pet-care, and personal-care manufacturing base supports demand for ingredients that can satisfy sustainability, provenance, and formulation-performance requirements.
United Kingdom. The United Kingdom is projected to reach USD 17.7 million by 2035 and grow at a 4.1% CAGR (2026–2035). Scottish salmon processing supplies a meaningful by-product stream, while established supplement and sports-nutrition channels provide an important commercial outlet for higher-value fractions.
France. France generated USD 11.8 million in 2025 and is projected to reach USD 17.7 million by 2035. Seafood-processing clusters and the country's cosmetics industry create complementary supply and demand conditions, particularly for premium marine-derived ingredients with clear source traceability.
Asia Pacific Marine Protein Hydrolysate Market Analysis
Asia Pacific generated USD 85.1 million in 2025 and is projected to reach USD 146.9 million by 2035. Its growth is underpinned by large-scale aquaculture, deep seafood-processing capacity, and increasing adoption of functional food, supplement, and personal-care ingredients, positioning the region as both a demand center and a growing production base.
China. China generated USD 34.0 million in 2025 and is projected to reach USD 61.7 million by 2035. Extensive aquaculture and seafood processing provide abundant raw-material streams, while domestic demand spans feed, food, and functional-ingredient applications.
Japan. Japan is projected to reach USD 26.4 million by 2035 and represented 20.0% of Asia Pacific revenue in 2025. The market's established interest in marine bioactives and specialized nutrition supports demand for high-quality peptide ingredients in functional foods, supplements, and medical-nutrition products.
South Korea. South Korea generated USD 12.8 million in 2025 and is expected to grow at a 4.1% CAGR (2026–2035). Demand is supported by the intersection of health supplements and beauty-focused product development, where marine peptides can support premium formulation narratives.
India. India is projected to reach USD 20.6 million by 2035 and grow at a 7.3% CAGR (2026–2035). Expanding shrimp aquaculture and processing are increasing the availability of recoverable marine co-products, while feed demand and emerging export-oriented production create room for capacity development.
Latin America Marine Protein Hydrolysate Market Analysis
Latin America generated USD 23.3 million in 2025 and is forecast to grow at a 3.7% CAGR (2026–2035). Strong access to pelagic and aquaculture raw materials supports production potential, although feed-market price sensitivity and less-developed premium nutrition channels temper near-term demand expansion.
Brazil. Brazil generated USD 10.5 million in 2025 and is projected to reach USD 15.1 million by 2035. Domestic aquaculture and livestock-feed demand remain central, while pet food and food applications provide a gradual route toward higher-value ingredient adoption.
Mexico. Mexico is projected to reach USD 8.4 million by 2035 and expand at a 3.7% CAGR (2026–2035). Shrimp farming and Pacific fisheries provide feedstock availability, with pet food and functional food representing emerging channels for processors able to develop differentiated products.
Middle East & Africa Marine Protein Hydrolysate Market Analysis
Middle East & Africa is projected to reach USD 21.4 million by 2035 and accounted for 5.8% of market revenue in 2025. The region is relatively import dependent, with demand concentrated in aquaculture feed, livestock nutrition, and select premium consumer-product channels; limited local processing infrastructure constrains broader adoption.
Saudi Arabia. Saudi Arabia generated USD 5.1 million in 2025 and is projected to reach USD 6.8 million by 2035. Coastal aquaculture development is creating incremental demand for performance-oriented feed inputs, although the market remains smaller than major Asian production centers.
UAE. The UAE generated USD 4.3 million in 2025 and is expected to grow at a 2.3% CAGR (2026–2035). Its role as a specialty-ingredient distribution hub supports demand for hydrolysates used in functional foods, sports nutrition, and premium consumer applications.
South Africa. South Africa is projected to reach USD 4.3 million by 2035, up from USD 3.4 million in 2025. Fisheries processing provides a modest local feedstock base, while livestock and animal-feed manufacturing remain the principal demand anchors.
GMI Analyst View
We expect regional performance to separate increasingly by application mix and supply-chain maturity. North America and Europe are better positioned to capture premium value through specialized nutrition and personal-care applications, while Asia Pacific combines the strongest volume outlook with a growing ability to process domestic marine by-products. Producers that establish local sourcing and technical partnerships early should be better placed as these regional models diverge.
Marine Protein Hydrolysate Market Share & Competitive Landscape
The marine protein hydrolysate market share landscape is moderately fragmented, with the top five players collectively accounting for 29.1% of global revenue in 2025. Competition is shaped by access to marine feedstock, processing technology, quality systems, customer qualification cycles, and the ability to serve both high-volume feed applications and specialized human-health markets.
Hofseth BioCare ASA held a 7.9% revenue share in 2025. Its positioning centers on low-temperature enzymatic processing of Norwegian salmon by-products and a portfolio that spans bioactive peptides, collagen-related fractions, and marine oils for nutrition, pet food, and feed markets. This breadth gives the company exposure to the market's shift toward more differentiated marine ingredients.
Copalis Sea Solutions accounted for a 5.7% revenue share in 2025. The company benefits from access to seafood-processing streams in France and serves aquafeed, pet food, and cosmetic applications, illustrating the advantage of proximity to concentrated raw-material sources and premium European ingredient customers.
Omega Protein Corporation held a 5.3% revenue share in 2025. Its Gulf Coast processing network and established North American distribution relationships support a strong position in feed-oriented marine proteins while providing a platform for participation in human nutrition applications.
Darling Ingredients Inc. and Seagarden AS remain relevant competitors through their broader animal-origin ingredient capabilities and specialized Norwegian marine-hydrolysate offerings, respectively. Other participants, including Pelagia AS, TripleNine Group A/S, Croda International Plc, Scanbio Marine Group AS, Sopropeche, Pure Marine Biotech Ltd, Mukka Proteins Limited, Janatha Fish Meal & Oil Products, Sociedad Pesquera Landes SA, and Zhonghai Ocean Technology Co., Ltd., reflect the market's geographic and value-chain diversity. Competitive advantage increasingly depends on converting regional seafood-processing access into stable, well-characterized ingredients that can meet customer-specific performance and compliance requirements.
Recent Industry Developments
In July 2026, Industrial Pesquera Santa Priscila received Ecuadorian regulatory approval to acquire selected hydrolysate production assets from Proteinas del Ecuador, strengthening its integrated capability in fish and shrimp protein hydrolysates for aquafeed applications [6]Aquafeed.com. "Santa Priscila acquires Ecuaprotein hydrolysate assets." aquafeed.com. The transaction reflects the strategic value of direct control over hydrolysate production within integrated aquaculture supply chains.
In January 2026, GC Rieber AS acquired all shares in Biomega Group AS, bringing a processor of Atlantic salmon and trout by-products under Norwegian industrial ownership [7]GC Rieber AS. "GC Rieber AS acquires Biomega Group AS to secure continued industrial development." gcrieber.no. The acquisition underscores the importance of maintaining specialized enzymatic-processing capacity for marine proteins and oils serving animal feed, human nutrition, and pet food markets.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →